103 related articles for article (PubMed ID: 8616801)
1. Altered CD3 chain and cytokine gene expression in tumor infiltrating T lymphocytes during the development of mesothelioma.
Jarnicki AG; Fitzpatrick DR; Robinson BW; Bielefeldt-Ohmann H
Cancer Lett; 1996 May; 103(1):1-9. PubMed ID: 8616801
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of interleukin-2 and CD3 triggering on cytokine gene transcription and secretion in cultured tumor infiltrating lymphocytes.
Filgueira L; Zuber M; Juretic A; Lüscher U; Caetano V; Harder F; Garotta G; Heberer M; Spagnoli GC
Cell Immunol; 1993 Aug; 150(1):205-18. PubMed ID: 8343966
[TBL] [Abstract][Full Text] [Related]
3. Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor-infiltrating lymphocytes.
Wang Q; Redovan C; Tubbs R; Olencki T; Klein E; Kudoh S; Finke J; Bukowski RM
Int J Cancer; 1995 Jun; 61(6):780-5. PubMed ID: 7790111
[TBL] [Abstract][Full Text] [Related]
4. The pattern of cytokine gene expression in freshly excised human metastatic melanoma suggests a state of reversible anergy of tumor-infiltrating lymphocytes.
Lüscher U; Filgueira L; Juretic A; Zuber M; Lüscher NJ; Heberer M; Spagnoli GC
Int J Cancer; 1994 May; 57(4):612-9. PubMed ID: 8181865
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta: antisense RNA-mediated inhibition affects anchorage-independent growth, tumorigenicity and tumor-infiltrating T-cells in malignant mesothelioma.
Fitzpatrick DR; Bielefeldt-Ohmann H; Himbeck RP; Jarnicki AG; Marzo AL; Robinson BW
Growth Factors; 1994; 11(1):29-44. PubMed ID: 7833058
[TBL] [Abstract][Full Text] [Related]
6. Dominant TCR alpha-chain clonotypes and interferon-gamma are expressed in the pancreas of patients with recent-onset insulin-dependent diabetes mellitus.
Yamagata K; Nakajima H; Tomita K; Itoh N; Miyagawa J; Hamaguchi T; Namba M; Tamura S; Kawata S; Kono N; Kuwajima M; Noguchi T; Hanafusa T; Matsuzawa Y
Diabetes Res Clin Pract; 1996 Sep; 34(1):37-46. PubMed ID: 8968689
[TBL] [Abstract][Full Text] [Related]
7. T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors.
Alexander JP; Kudoh S; Melsop KA; Hamilton TA; Edinger MG; Tubbs RR; Sica D; Tuason L; Klein E; Bukowski RM
Cancer Res; 1993 Mar; 53(6):1380-7. PubMed ID: 8443817
[TBL] [Abstract][Full Text] [Related]
8. Patho- and immunobiology of malignant mesothelioma: characterisation of tumour infiltrating leucocytes and cytokine production in a murine model.
Bielefeldt-Ohmann H; Fitzpatrick DR; Marzo AL; Jarnicki AG; Himbeck RP; Davis MR; Manning LS; Robinson BW
Cancer Immunol Immunother; 1994 Dec; 39(6):347-59. PubMed ID: 8001022
[TBL] [Abstract][Full Text] [Related]
9. The cytokine microenvironment of human colon carcinoma. Lymphocyte expression of tumor necrosis factor-alpha and interleukin-4 predicts improved survival.
Barth RJ; Camp BJ; Martuscello TA; Dain BJ; Memoli VA
Cancer; 1996 Sep; 78(6):1168-78. PubMed ID: 8826937
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the activation status of tumor infiltrating and peripheral lymphocytes of patients with adenocarcinomas and benign hyperplasia of the prostate.
Elsässer-Beile U; Przytulski B; Gierschner D; Grussenmeyer T; Katzenwadel A; Leiber C; Deckart A; Wetterauer U
Prostate; 2000 Sep; 45(1):1-7. PubMed ID: 10960837
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell lines.
Nash MA; Lenzi R; Edwards CL; Kavanagh JJ; Kudelka AP; Verschraegen CF; Platsoucas CD; Freedman RS
Clin Exp Immunol; 1998 May; 112(2):172-80. PubMed ID: 9649178
[TBL] [Abstract][Full Text] [Related]
12. Effects of hemorrhage on cytokine gene transcription.
Shenkar R; Abraham E
Lymphokine Cytokine Res; 1993 Aug; 12(4):237-47. PubMed ID: 8218596
[TBL] [Abstract][Full Text] [Related]
13. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
14. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman JJ; Smith CV; Pecorelli S; Radominska-Pandya A; Cannon MJ; Parham GP
Gynecol Obstet Invest; 2001; 51(4):254-61. PubMed ID: 11408737
[TBL] [Abstract][Full Text] [Related]
16. Modulation of tumor-infiltrating lymphocyte cytolytic activity against human non-small cell lung cancer.
Ortegel JW; Staren ED; Faber LP; Warren WH; Braun DP
Lung Cancer; 2002 Apr; 36(1):17-25. PubMed ID: 11891029
[TBL] [Abstract][Full Text] [Related]
17. T lymphocytes infiltrating sites of tumor rejection and progression display identical V beta usage but different cytotoxic activities.
Kurt RA; Park JA; Panelli MC; Schluter SF; Marchalonis JJ; Carolus B; Akporiaye ET
J Immunol; 1995 Apr; 154(8):3969-74. PubMed ID: 7706735
[TBL] [Abstract][Full Text] [Related]
18. Tumor-host interaction: analysis of cytokines, growth factors, and tumor-infiltrating lymphocytes in ovarian carcinomas.
Merogi AJ; Marrogi AJ; Ramesh R; Robinson WR; Fermin CD; Freeman SM
Hum Pathol; 1997 Mar; 28(3):321-31. PubMed ID: 9042797
[TBL] [Abstract][Full Text] [Related]
19. Regression of AK7 malignant mesothelioma established in immunocompetent mice following intratumoral gene transfer of interferon gamma.
Cordier Kellerman L; Valeyrie L; Fernandez N; Opolon P; Sabourin JC; Maubec E; Le Roy P; Kane A; Legrand A; Abina MA; Descamps V; Haddada H
Cancer Gene Ther; 2003 Jun; 10(6):481-90. PubMed ID: 12768194
[TBL] [Abstract][Full Text] [Related]
20. Combination anti-CD2 and anti-CD3 monoclonal antibodies induce tolerance while altering interleukin-2, interleukin-4, tumor necrosis factor, and transforming growth factor-beta production.
Chavin KD; Qin L; Lin J; Woodward JE; Baliga P; Bromberg JS
Ann Surg; 1993 Oct; 218(4):492-501; discussion 501-3. PubMed ID: 8215640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]